AzTrials
AzTrials

HIV InfectionsNCT00640653

Efficacy of an Abstinence-Only HIV Risk-Reduction Intervention for Young African-American Adolescents

A study testing Abstinence-only HIV/STD risk-reduction intervention, Safer-sex-only HIV/STD risk-reduction intervention and Long comprehensive HIV/STD risk-reduction intervention in people with HIV Infections and Sexually Transmitted Diseases, run by University of Pennsylvania at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will develop and evaluate the effectiveness of culturally appropriate HIV/sexually transmitted disease risk-reduction interventions in reducing sexual risk behavior among young African-American adolescents. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
HIV Infections, Sexually Transmitted Diseases
What is being tested?
Abstinence-only HIV/STD risk-reduction intervention, Safer-sex-only HIV/STD risk-reduction intervention and Long comprehensive HIV/STD risk-reduction intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
662 participants
Where
1 siteUnited States
Study dates
Sep 2001to Aug 2004
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Grade 6 or 7 student at a participating school
  • Written parent or guardian consent to participate
  • Self-identifies as African American or black

Who cannot join

  • Those not meeting inclusion criteria were excluded.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

Other trials in United States

About this study

Official title: HIV/Sexually Transmitted Disease (STD) Prevention Interventions for Black Adolescents

This study will develop and evaluate the effectiveness of culturally appropriate HIV/sexually transmitted disease risk-reduction interventions in reducing sexual risk behavior among young African-American adolescents.

Read the detailed description

Adolescents risk the negative consequences of early sexual involvement, including not only HIV, but other sexually transmitted diseases (STDs) and unintended pregnancies. Compared with older adults, young people, especially African-American young people, are at higher risk of acquiring an STD. Specifically, people 15 to 24 years of age acquire nearly 50% of all new STDs in the United States, but this age group represents only 25% of the sexually active population. Adolescents are especially vulnerable to STD infections because of a lack of education about proper condom use and consequences of sexual risk behaviors. Previous research has suggested that behavioral interventions can reduce adolescents' sexual behaviors tied to risk of acquiring STDs. Nevertheless, there is continuous debate over the appropriateness and effectiveness of different types of adolescent sexual-risk-reduction interventions, including abstinence education or comprehensive sexual education. Few studies have tested the long-term effectiveness of abstinence education, which emphasizes delaying sexual initiation for sexually inexperienced adolescents. This study will compare the effectiveness of an abstinence-only HIV/STD risk-reduction intervention with other types of interventions in reducing sexual risk behavior among young African-American adolescents.

Participation in this study will last 24 months. Participants at participating schools will be randomly assigned to one of five treatment groups:

  • Abstinence-only group participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence. This is not an abstinence-until-marriage intervention; the target behavior is abstaining from sexual activity until later in life when the adolescent is more prepared to handle the consequences. The intervention is not designed to affect condom use.
  • Safer-sex-only group participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for using condoms during sexual intercourse. The intervention is not designed to influence abstinence.
  • Long comprehensive group participants will attend three sessions consisting of twelve 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence and for using condoms if participants decide to be sexually active. The intervention will consist of 4 hours each of the safer-sex-specific content, the abstinence-specific content, and the general content that is common to both of the single-component interventions.
  • Short comprehensive group participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence and for using condoms if participants decide to be sexually active.
  • Health promotion control participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for avoiding cigarette smoking and for incorporating a healthful diet, aerobic exercise, and breast and testicular self-examinations. The control intervention will focus on reducing risk of heart disease, hypertension, diabetes, and certain cancers.

Sessions for all groups will be led by trained adult facilitators and will include group discussions, videos, games, brainstorming, experiential exercises, and skill-building activities designed to be educational, interactive, and entertaining. All participants will complete self-reports concerning sexual behaviors, condom use, and knowledge about STDs at baseline and Months 3, 6, 12, 18, and 24 of follow-up.

Being tested
Abstinence-only HIV/STD risk-reduction intervention, Safer-sex-only HIV/STD risk-reduction intervention, Long comprehensive HIV/STD risk-reduction intervention, Short comprehensive HIV/STD risk-reduction intervention, Health promotion control intervention
Keywords
Sexual Behavior, Abstinence, Intervention Studies, HIV, Sexually Transmitted Infection, Theory of Planned Behavior, HIV Seronegativity
Medical subject headings
HIV Infections, Sexually Transmitted Diseases, Sexual Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Abstinence-only HIV/STD risk-reduction interventionBehavioural

    Also called Abstinence

    Participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence. The intervention is not an abstinence-until-marriage intervention; the target behavior is abstaining from sexual activity until later in life when the adolescent is more prepared to handle the consequences. The intervention does not contain inaccurate information, portray sex in a negative light, or employ a moralistic tone. It is not designed to affect condom use.

  • Safer-sex-only HIV/STD risk-reduction interventionBehavioural

    Also called Condom-use intervention

    Participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for using condoms during sexual intercourse. The intervention is not designed to influence abstinence.

  • Long comprehensive HIV/STD risk-reduction interventionBehavioural

    Also called Abstinence and condom-use intervention, Abstinence-plus intervention

    Participants will attend three sessions consisting of twelve 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence and for using condoms if participants decide to be sexually active. The intervention consists of the safer-sex-specific content (4 hours), the abstinence-specific content (4 hours), and the general content that is common to both of the single-component interventions (4 hours).

  • Short comprehensive HIV/STD risk-reduction interventionBehavioural

    Also called Abstinence and condom-use intervention, Abstinence-plus intervention

    Participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for practicing abstinence and for using condoms if participants decide to be sexually active.

  • Health promotion control interventionBehavioural

    Also called Chronic disease prevention intervention

    Participants will attend two sessions consisting of eight 1-hour modules that are designed to increase knowledge, motivation, and skill for avoiding cigarette smoking and for incorporating a healthful diet, aerobic exercise, and breast and testicular self-examinations. The control intervention will focus on reducing risk of heart disease, hypertension, diabetes, and certain cancers. The intervention provides a control for "Hawthorne effects" to reduce the likelihood that the HIV/STD interventions' effects can be attributed to group interaction and special attention.

Study groups in NCT00640653
Study groupRoleWhat they receive
Abstinence-onlyExperimentalParticipants will receive the abstinence-only HIV/STD risk-reduction intervention.
Receives: Behavioral: Abstinence-only HIV/STD risk-reduction intervention
Safer-sex onlyExperimentalParticipants will receive the safer-sex-only HIV/STD risk-reduction intervention.
Receives: Behavioral: Safer-sex-only HIV/STD risk-reduction intervention
Comprehensive-longExperimentalParticipants will receive the 12-h long comprehensive HIV/STD risk-reduction intervention.
Receives: Behavioral: Long comprehensive HIV/STD risk-reduction intervention
Comprehensive-shortExperimentalParticipants will receive the 8-h short comprehensive HIV/STD risk-reduction intervention.
Receives: Behavioral: Short comprehensive HIV/STD risk-reduction intervention
Health-promotion controlActive comparatorParticipants will receive the health promotion control intervention.
Receives: Behavioral: Health promotion control intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-report of Ever Having Sexual Intercourse

    Self-reported sexual initiation during the follow-up period among participants who reported never having sexual intercourse at baseline.

    Measured: 24 months post-intervention

Secondary outcomes (4)
  1. Self-reported Sexual Intercourse in the Past 3 Months

    Self-report of having sexual intercourse in the past 3 months

    Measured: Measured at baseline and 3, 6, 12, 18, and 24 months post-intervention

  2. Self-report of Having Multiple Sexual Partners in the Past 3 Months

    Self-report of having sexual intercourse with more than one partner in the pat 3 months.

    Measured: Measured at baseline and 3, 6, 12, 18, and 24 months post-intervention

  3. Self-reported Consistent Condom Use in the Past 3 Months

    Self-report of using a condom during every sexual intercourse act in the past 3 months

    Measured: Measured at baseline and 3, 6, 12, 18, and 24 months post-intervention

  4. Self-report of Having Sexual Intercourse Without Using a Condom During the Past 3 Months

    Measured: Measured at baseline and3, 6, 12, 18, and 24 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2008 (estimated)
  2. Study startSep 2001
  3. Primary completionAug 2004
  4. Study completionAug 2004

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
662 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00640653
Sponsor's protocol ID
R01MH062049
Other IDs
R01MH062049, DAHBR 9A-ASPA
Status last verified
Nov 2017
First submitted
19 Mar 2008
Last updated
13 Dec 2017
Data monitoring committee
No

Publications

  • Jemmott JB 3rd, Jemmott LS, Fong GT. Efficacy of a theory-based abstinence-only intervention over 24 months: a randomized controlled trial with young adolescents. Arch Pediatr Adolesc Med. 2010 Feb;164(2):152-9. doi: 10.1001/archpediatrics.2009.267.

    PubMed 20124144
  • Zhang J, Jemmott JB 3rd, Jemmott LS. Mediation and moderation of an efficacious theory-based abstinence-only intervention for African American adolescents. Health Psychol. 2015 Dec;34(12):1175-84. doi: 10.1037/hea0000244. Epub 2015 Jul 27.

    PubMed 26214076

Questions about this trial

What is this clinical trial studying?

A study testing Abstinence-only HIV/STD risk-reduction intervention, Safer-sex-only HIV/STD risk-reduction intervention and Long comprehensive HIV/STD risk-reduction intervention in people with HIV Infections and Sexually Transmitted Diseases, run by University of Pennsylvania at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 13 Dec 2017). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-report of Ever Having Sexual Intercourse (time frame: 24 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00640653, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in